These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 10942188
1. Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay. Berry DJ, Patsalos PN. Ther Drug Monit; 2000 Aug; 22(4):460-4. PubMed ID: 10942188 [Abstract] [Full Text] [Related]
2. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay. Snozek CL, Rollins LA, Peterson PW, Langman LJ. Ther Drug Monit; 2010 Feb; 32(1):107-11. PubMed ID: 20010458 [Abstract] [Full Text] [Related]
3. Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay. Christensen J, Højskov CS, Poulsen JH. Ther Drug Monit; 2002 Oct; 24(5):658-64. PubMed ID: 12352939 [Abstract] [Full Text] [Related]
4. Topiramate concentration in saliva: an alternative to serum monitoring. Miles MV, Tang PH, Glauser TA, Ryan MA, Grim SA, Strawsburg RH, deGrauw TJ, Baumann RJ. Pediatr Neurol; 2003 Aug; 29(2):143-7. PubMed ID: 14580658 [Abstract] [Full Text] [Related]
5. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R. J Pharm Biomed Anal; 2008 Dec 15; 48(5):1392-6. PubMed ID: 18980824 [Abstract] [Full Text] [Related]
6. Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of teicoplanin concentrations in human plasma. Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P. J Clin Lab Anal; 2013 Mar 15; 27(2):96-8. PubMed ID: 23378010 [Abstract] [Full Text] [Related]
9. An improved gas chromatography assay for topiramate monitoring in pediatric patients. Tang PH, Miles MV, Glauser TA, Coletta L, Doughman N, Doose D, Frey M, DeGrauw A. Ther Drug Monit; 2000 Apr 15; 22(2):195-201. PubMed ID: 10774633 [Abstract] [Full Text] [Related]
10. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T. Epilepsia; 2002 Oct 15; 43(10):1157-60. PubMed ID: 12366729 [Abstract] [Full Text] [Related]
15. Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy. Schwabe MJ, Wheless JW. J Child Neurol; 2001 Nov 15; 16(11):806-8. PubMed ID: 11732765 [Abstract] [Full Text] [Related]
17. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Shank RP, Doose DR, Streeter AJ, Bialer M. Epilepsy Res; 2005 Feb 15; 63(2-3):103-12. PubMed ID: 15715969 [Abstract] [Full Text] [Related]
18. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy. Vovk T, Jakovljević MB, Kos MK, Janković SM, Mrhar A, Grabnar I. Biol Pharm Bull; 2010 Feb 15; 33(7):1176-82. PubMed ID: 20606310 [Abstract] [Full Text] [Related]